{"id":51374,"date":"2022-11-30T09:02:07","date_gmt":"2022-11-30T08:02:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/"},"modified":"2022-11-30T09:02:07","modified_gmt":"2022-11-30T08:02:07","slug":"labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/","title":{"rendered":"LabGenius Wins Government Innovation Grant to Support the Development of ML-driven Cancer Therapies"},"content":{"rendered":"
\n

\nThe UK\u2019s innovation agency, Innovate UK, has awarded LabGenius Biomedical Catalyst funding to drive the development of their immunotherapy pipeline<\/i>\n<\/p>\n

LONDON–(BUSINESS WIRE)–#AI<\/a>–LabGenius, a pioneer in the use of machine learning (ML) for antibody-based drug discovery, today announced that it has been awarded a highly competitive Biomedical Catalyst (BMC) grant from Innovate UK. With this recent grant, LabGenius has secured a total of over \u00a31 million in government backing this year.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nLabGenius is pioneering the development of an ML-driven protein engineering <\/b>platform (EVA<\/i>\u2122<\/sup><\/i><\/b>). <\/b><\/i>To date, EVA<\/i><\/b> has co-optimised mono- and multi-specific single domain antibodies for biochemical and biofunctional properties, including stability, potency and selective tumour cell killing.\n<\/p>\n

\nThere are many different types of solid tumours that would benefit from highly selective immunotherapy treatments. This grant will be used to support the development of LabGenius\u2019 pipeline of antibody therapeutics by financing the discovery of best-in-class immune cell engager molecules with favourable selective killing profiles. To do this, LabGenius will use its platform technology to intelligently guide the search for protein designs that perform across multiple therapeutically valuable properties.\n<\/p>\n

\n\u201cWe\u2019re truly delighted with this result\u201d <\/i>said LabGenius\u2019 CEO and Founder, Dr. James Field<\/a>. \u201cThis grant will enhance LabGenius\u2019 ability to optimise an important class of immunotherapeutics and help us to accelerate drug candidates towards the clinic.\u201d<\/i>\n<\/p>\n

\nSpeaking to LabGenius\u2019 success, Chairman of LabGenius\u2019 Board and former CEO of Ablynx, Dr. Edwin Moses<\/a> commented \u201cThis is a great win for LabGenius as it further validates their ML-driven approach to antibody discovery. With this backing, the team can further expand their efforts to build a strong pipeline of molecules that would not have been identified through rational human design alone.\u201d<\/i>\n<\/p>\n

\n\u2013 end \u2013<\/b>\n<\/p>\n

\nAbout LabGenius<\/b>\n<\/p>\n

\nHeadquartered in London, LabGenius is a leading machine learning-driven protein engineering company. The company\u2019s core technology platform, EVA\u2122<\/sup><\/i><\/b>, enables the rapid discovery of novel therapeutic antibodies. LabGenius\u2019 highly multidisciplinary team brings together the very best minds from the fields of computer science, robotic automation and synthetic biology.\n<\/p>\n

\nFor more information, please visit www.labgeni.us<\/a>, or connect on Twitter<\/a>, LinkedIn<\/a> and Medium<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor more information, please contact:<\/b>
For media enquiries, please contact Lucy Shaw at press@labgeni.us<\/a>
For business development, please contact James Field at partnerships@labgeni.us<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The UK\u2019s innovation agency, Innovate UK, has awarded LabGenius Biomedical Catalyst funding to drive the development of their immunotherapy pipeline LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody-based drug discovery, today announced that it has been awarded a highly competitive Biomedical Catalyst (BMC) grant from Innovate UK. With this recent … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-51374","format-standard","category-industry"],"yoast_head":"\nLabGenius Wins Government Innovation Grant to Support the Development of ML-driven Cancer Therapies - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LabGenius Wins Government Innovation Grant to Support the Development of ML-driven Cancer Therapies - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The UK\u2019s innovation agency, Innovate UK, has awarded LabGenius Biomedical Catalyst funding to drive the development of their immunotherapy pipeline LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody-based drug discovery, today announced that it has been awarded a highly competitive Biomedical Catalyst (BMC) grant from Innovate UK. With this recent ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-30T08:02:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221130005020\/en\/1648033\/21\/LabGenius_MoA_subs.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"LabGenius Wins Government Innovation Grant to Support the Development of ML-driven Cancer Therapies\",\"datePublished\":\"2022-11-30T08:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/\"},\"wordCount\":386,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221130005020\\\/en\\\/1648033\\\/21\\\/LabGenius_MoA_subs.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/\",\"name\":\"LabGenius Wins Government Innovation Grant to Support the Development of ML-driven Cancer Therapies - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221130005020\\\/en\\\/1648033\\\/21\\\/LabGenius_MoA_subs.jpg\",\"datePublished\":\"2022-11-30T08:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221130005020\\\/en\\\/1648033\\\/21\\\/LabGenius_MoA_subs.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221130005020\\\/en\\\/1648033\\\/21\\\/LabGenius_MoA_subs.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LabGenius Wins Government Innovation Grant to Support the Development of ML-driven Cancer Therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LabGenius Wins Government Innovation Grant to Support the Development of ML-driven Cancer Therapies - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/","og_locale":"en_US","og_type":"article","og_title":"LabGenius Wins Government Innovation Grant to Support the Development of ML-driven Cancer Therapies - Pharma Trend","og_description":"The UK\u2019s innovation agency, Innovate UK, has awarded LabGenius Biomedical Catalyst funding to drive the development of their immunotherapy pipeline LONDON–(BUSINESS WIRE)–#AI–LabGenius, a pioneer in the use of machine learning (ML) for antibody-based drug discovery, today announced that it has been awarded a highly competitive Biomedical Catalyst (BMC) grant from Innovate UK. With this recent ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-30T08:02:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221130005020\/en\/1648033\/21\/LabGenius_MoA_subs.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"LabGenius Wins Government Innovation Grant to Support the Development of ML-driven Cancer Therapies","datePublished":"2022-11-30T08:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/"},"wordCount":386,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221130005020\/en\/1648033\/21\/LabGenius_MoA_subs.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/","url":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/","name":"LabGenius Wins Government Innovation Grant to Support the Development of ML-driven Cancer Therapies - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221130005020\/en\/1648033\/21\/LabGenius_MoA_subs.jpg","datePublished":"2022-11-30T08:02:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221130005020\/en\/1648033\/21\/LabGenius_MoA_subs.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221130005020\/en\/1648033\/21\/LabGenius_MoA_subs.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/labgenius-wins-government-innovation-grant-to-support-the-development-of-ml-driven-cancer-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"LabGenius Wins Government Innovation Grant to Support the Development of ML-driven Cancer Therapies"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51374"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51374\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}